Verily Raises $300M to Expand Precision Health Data Platform
Something about healthcare data has always felt like a library where half the books are locked, the other half are written in different languages, and everyone swears they have read them all. Then Verily walks in with a $300M reminder that maybe the problem was never the data. It was the way we have been trying to listen to it.
Dallas stamped on the dateline, but this story has been brewing since the Google X days when Andy Conrad decided biology deserved better software and less guesswork. Fast forward, and Verily Health Inc. is no longer the quiet science project in the corner. It is a platform play with teeth, pulling together multimodal health data and asking a simple question with expensive consequences: what if the signal is already there, just waiting for the right system to hear it?
Stephen Gillett, CEO, now holds the mic, and this latest round, led by Series X Capital with Alphabet, UCHealth, and the University of Colorado Anschutz stepping in, does not read like a routine capital raise. It feels more like a cap table rearranging itself for a different kind of tempo. Alphabet steps back to a significant minority stake, which in venture language usually means the kid can ride the bike without training wheels, but everyone is still watching the road.
The product is not trying to be flashy. Verily’s Pre platform is built to harmonize healthcare data, which is a polite way of saying it takes chaos and makes it usable. Research, clinical care, population health, all fed through a system designed to turn raw inputs into decisions that do not take 5 committees and a prayer. Add collaborations with Samsung’s Galaxy Watch and Salesforce’s Agentforce Health, and now the data is not just sitting still. It is moving, breathing, showing up where decisions actually get made.
What stands out is not just the size of the round. It is how they earned it. Years of shifting from experimental to operational, tightening the model, proving that precision health is not an empty label if the infrastructure can carry the weight. Partnerships that are not decorative but functional. A willingness to evolve the ownership structure so the business can scale beyond its origin story.
There is a lesson buried in here for anyone building in AI or healthcare or both. Capital does not chase ideas anymore. It chases systems that can absorb reality without breaking. Verily did not just promise intelligence. They built a way to deploy it where it matters, which is a much harder game.
And if you are in the room where care decisions get made, or you are selling into it, pay attention. Because when the data finally starts making sense, the companies that understand it will not just participate in the market. They will quietly start setting the terms.
